Compounds > fluorodeoxyglucose f18
Page last updated: 2024-08-24

fluorodeoxyglucose f18 and Cystadenocarcinoma, Mucinous

fluorodeoxyglucose f18 has been researched along with Cystadenocarcinoma, Mucinous in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (50.00)29.6817
2010's2 (33.33)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Bian, Y; Hu, Y; Tian, C; Wei, Q; Zhang, X1
Dong, A; Wang, Y; Zhai, Z; Zuo, C1
Hiyama, T; Iijima, T; Kato, K; Nagai, H; Saito, H; Sato, M; Shirasu, T; Yoshimi, F1
Canessa, JA; Galaz, R; González, P; Humeres, P; Jofré, J; Larach, JA; Massardo, T; Morales, B; Parra, J; Sierralta, P1
Iwasaki, T; Kawahara, K; Nagano, T; Nakagawa, K1
Doi, R; Higashi, T; Hosotani, R; Imamura, M; Ishimori, T; Konishi, J; Mamede, MH; Nakamoto, Y; Saga, T; Wada, M1

Other Studies

6 other study(ies) available for fluorodeoxyglucose f18 and Cystadenocarcinoma, Mucinous

ArticleYear
18F-FDG PET/CT Findings in a Patient With Primary Mucinous Cystadenocarcinoma of the Breast.
    Clinical nuclear medicine, 2020, Volume: 45, Issue:2

    Topics: Breast Neoplasms; Cystadenocarcinoma, Mucinous; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals

2020
MRI, enhanced CT, and FDG PET/CT in primary retroperitoneal mucinous cystadenocarcinoma.
    Clinical nuclear medicine, 2015, Volume: 40, Issue:1

    Topics: Cystadenocarcinoma, Mucinous; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retroperitoneal Neoplasms; Tomography, X-Ray Computed

2015
F-18 FDG accumulation in mucinous cystic neoplasm of pancreas.
    Clinical nuclear medicine, 2011, Volume: 36, Issue:1

    Topics: Adult; Cystadenocarcinoma, Mucinous; Female; Fluorodeoxyglucose F18; Humans; Pancreatic Neoplasms; Radionuclide Imaging; Tomography, X-Ray Computed

2011
[Fluorodeoxiglucose F18 positron emission tomography imaging (F18FDG) for the assessment of rising levels of serum CA 19-9 in pancreatic mucinous cystadenocarcinoma. Report of one case].
    Revista medica de Chile, 2004, Volume: 132, Issue:3

    Topics: Adult; CA-19-9 Antigen; Cystadenocarcinoma, Mucinous; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms

2004
Pulmonary mucinous cystadenocarcinoma: an extremely rare tumor presenting as a cystic lesion of the lung.
    General thoracic and cardiovascular surgery, 2007, Volume: 55, Issue:3

    Topics: Aged; Cystadenocarcinoma, Mucinous; Cysts; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Thoracotomy; Tomography, X-Ray Computed

2007
Relationship between retention index in dual-phase (18)F-FDG PET, and hexokinase-II and glucose transporter-1 expression in pancreatic cancer.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2002, Volume: 43, Issue:2

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Cystadenocarcinoma, Mucinous; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Hexokinase; Humans; Immunohistochemistry; Male; Middle Aged; Monosaccharide Transport Proteins; Pancreatic Neoplasms; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed

2002